Corona Remedies Ltd to Review Q1 Financial Results in Upcoming Board Meeting
Corona Remedies Limited has scheduled a meeting of its Board of Directors on Friday, July 31, 2026. The primary agenda for the meeting includes the consideration and approval of the company's unaudited financial results for both standalone and consolidated positions.The financial results to be reviewed pertain to the first quarter and the three months ended on June 30, 2026. In addition to the financial review, the Board will deliberate on other business matters during the session.
In conjunction with these proceedings, the trading window for dealing in the securities of the company remains closed until Sunday, August 02, 2026. This measure follows the previously communicated closure initiated on June 29, 2026.
| Event Detail | Information |
|---|---|
| Company Name | Corona Remedies Ltd |
| Meeting Date | July 31, 2026 |
| Reporting Period | Quarter ended June 30, 2026 |
| Trading Window Closure | Until August 02, 2026 |
CORONA Stock Price Movement
CORONA Remedies Limited shares today slipped by 0.24% to settle at ₹2060.00 in post-market trading. The stock saw a total turnover of 25,741 shares after finding a floor of ₹2018.90 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.